系统性右心室患者心力衰竭:一项多中心研究,长期随访
Mohammad Mostafa Ansari Ramandi1, Werner Budts2, Jolien W Roos-Hesselink3
1Department of Cardiology, University of Groningen, Center for Congenital Heart Disease, University Medical Center Groningen, Groningen, The Netherlands.
European journal of heart failure
|April 25, 2025
概括
患有全身右心室 (sRV) 和大动脉转移 (TGA) 的成年人面临心力衰竭 (HF) 的风险. 一个新的工具使用五个因素来预测HF住院,帮助临床实践.
科学领域:
- 心脏病学 心脏病学
- 成年人的先天性心脏病
- 心脏衰竭研究研究
背景情况:
- 患有大动脉转移 (TGA) 和全身右心室 (sRV) 的成年人容易患心力衰竭 (HF).
- 有效的风险分层对于管理这些患者和预防HF住院至关重要.
研究的目的:
- 调查与TGA和sRV的成年人心力衰竭住院相关的风险因素.
- 开发和验证一种新的风险分层工具,用于预测该人群中HF住院治疗.
主要方法:
- 对522名TGA和sRV成年患者的回顾性分析,没有先前HF住院治疗.
- 考克斯回归分析以确定HF住院的独立预测因素.
- 基于临床变量开发10年风险评分.
主要成果:
- 在持续17.9年的中位数随访期间,24.3%的患者至少有一次住院治疗HF.
- HF住院的主要预测因素包括年龄,NYHA功能类≥II,QRS持续时间>120毫秒,心房动和中度/严重的RV功能障碍.
- 开发的风险分层工具显示C统计值为0.868 (95%CI为0.823-0.913).
结论:
- 很大一部分患有TGA和sRV的成年人面临HF住院的风险.
- 一个简单的,临床上可访问的风险评分利用五个变量可以有效地识别高风险患者.
- 这种工具可以优化风险预测,并指导TGA/sRV患者的临床管理策略.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


